Maywufa Company Ltd. (1731.TW)

TWD 22.25

(0.23%)

Operating Expenses Summary of Maywufa Company Ltd.

  • Maywufa Company Ltd.'s latest annual operating expenses in 2023 was 854.37 Million TWD , up 6.63% from previous year.
  • Maywufa Company Ltd.'s latest quarterly operating expenses in 2024 Q2 was 171.28 Million TWD , down -13.04% from previous quarter.
  • Maywufa Company Ltd. reported a annual operating expenses of 618.05 Million TWD in annual operating expenses 2022, down -6.39% from previous year.
  • Maywufa Company Ltd. reported a annual operating expenses of 660.25 Million TWD in annual operating expenses 2021, up 30.5% from previous year.
  • Maywufa Company Ltd. reported a quarterly operating expenses of 196.96 Million TWD for 2024 Q1, up 5.6% from previous quarter.
  • Maywufa Company Ltd. reported a quarterly operating expenses of 159.6 Million TWD for 2023 Q2, down -0.62% from previous quarter.

Annual Operating Expenses Chart of Maywufa Company Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Maywufa Company Ltd. (2023 - 2009)

Year Operating Expenses Operating Expenses Growth
2023 854.37 Million TWD 6.63%
2022 618.05 Million TWD -6.39%
2021 660.25 Million TWD 30.5%
2020 505.93 Million TWD -3.07%
2019 521.95 Million TWD 2.99%
2018 506.79 Million TWD -2.18%
2017 518.09 Million TWD 5.15%
2016 492.7 Million TWD -4.79%
2015 517.48 Million TWD 6.14%
2014 487.57 Million TWD 7.33%
2013 454.25 Million TWD -7.01%
2012 488.47 Million TWD -8.23%
2011 532.31 Million TWD -13.17%
2010 613.05 Million TWD -1.94%
2009 625.18 Million TWD 0.0%

Peer Operating Expenses Comparison of Maywufa Company Ltd.

Name Operating Expenses Operating Expenses Difference
Grape King Bio Ltd 6.03 Billion TWD 85.853%
Standard Chem & Pharm CO., LTD. 1.46 Billion TWD 41.714%
ScinoPharm Taiwan, Ltd. 901.49 Million TWD 5.228%
Lotus Pharmaceutical Co., Ltd. 4.48 Billion TWD 80.933%
LIWANLI Innovation Co., Ltd. 54.86 Million TWD -1457.198%
YungShin Global Holding Corporation 2.04 Billion TWD 58.277%
PhytoHealth Corporation 67.64 Million TWD -1163.06%
SCI Pharmtech, Inc. 190.02 Million TWD -349.615%
Formosa Laboratories, Inc. 1.24 Billion TWD 31.56%
PharmaEssentia Corporation 4.49 Billion TWD 80.993%
Bora Pharmaceuticals Co., LTD. 1.74 Billion TWD 50.957%